Analysts who follow F-Star Therapeutics Inc (FSTX) on average expect it to gain 23.46% over the next twelve months. Those same analysts give the stock an average rating of Hold. That average rating earns the stock an Analyst Ranking of 6, which means it ranks higher than 6 of stocks, based on data compiled by InvestorsObserver.
Wall Street analysts are rating FSTX a Hold today. Find out what this means to you and get the rest of the rankings on FSTX!